雜志介紹

Drug Development Research雜志介紹

《Drug Development Research》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱藥物開發(fā)研究，本刊主要出版、報(bào)道醫(yī)學(xué)-CHEMISTRY, MEDICINAL領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為3.5，最新CiteScore 指數(shù)為6.4。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• Berberine targets KIF20A and CCNE2 to inhibit the progression of nonsmall cell lung cancer via the PI3K/AKT pathway

  Author: Wang, Qi; Wu, Hua; Wu, Qingquan; Zhong, Sheng

• Dioscin induces osteosarcoma cell apoptosis by upregulating ROS-mediated P38 MAPK signaling

  Author: Zheng, Gui-zhou; Zhang, Qi-hao; Chang, Bo; Xie, Peng; Liao, Hang; Du, Shi-xin; Li, Xue-dong

• Discovery of pyrazole-carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti-tumor candidates

  Author: Man, Ruo-Jun; Lu, Tian; Zheng, Chi-Chong; Li, Tong; Wu, Meng-Ke; Li, Dong-Dong; He, Xue-Mei

• Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway

  Author: Liu, Zhiguang; Zhu, Xiaochun; Xu, Chenglin; Min, Feng; Yu, Guofeng; Chen, Chuhong

英文介紹

Drug Development Research雜志英文介紹

Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.